CIK 0000318306
- Non-accelerated filer
- Smaller reporting company
ABEONA THERAPEUTICS INC.
Sign in to watch- Ticker
- ABEO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 830221517
- Phone
- +1 646-813-4701
- Business address
- 6555 CARNEGIE AVE, 4TH FLOOR, CLEVELAND, OH, 44103
- Former names
- PLASMATECH BIOPHARMACEUTICALS INC, ACCESS PHARMACEUTICALS INC, CHEMEX PHARMACEUTICALS INC
- 4 Open-market sale Director sold 20,000 shares at $0.15 ($3,098)
- 4 Shares withheld for taxes Chief Executive Officer gave up 81,525 shares (to pay taxes)
- 4 Open-market sale Director sold 35,000 shares at $0.16 ($5,464)
- 4 Grant or award Chief Financial Officer acquired 200,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale SVP, General Counsel sold 8,880 shares at $0.57 ($5,035)
- 4 Open-market sale SVP, General Counsel sold 8,880 shares at $0.89 ($7,894)
- 4 Grant or award Chief Executive Officer acquired 50,000 shares (grant or award)
- 4 Open-market sale SVP, General Counsel sold 25,734 shares at $0.90 ($23,271)
- 4 Open-market sale Director sold 25,000 shares at $0.97 ($24,150)
- 4 Open-market sale SVP, General Counsel sold 25,210 shares at an average $1.05 ($26,484)
- 4 Open-market sale Chief Financial Officer sold 29,122 shares at $1.05 ($30,596)
- 4 Open-market sale Chief Executive Officer sold 45,409 shares at $1.09 ($49,382)
- 4 Grant or award SVP, General Counsel acquired 136,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Chief Financial Officer acquired 238,000 shares (grant or award)
- 4 Grant or award SVP, Head of Res./Clin. Dev. acquired 300,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 77,181 shares (grant or award)
- 4 Grant or award Director acquired 38,590 shares (grant or award)
Page 10 of 20 · 394 filings